NCT00080899 2015-03-06
Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
Clinical Trials
10 trialsNCT00288067 2014-10-06
Fenretinide and Rituximab in Treating Patients With B-Cell Non-Hodgkin Lymphoma
National Cancer Institute (NCI)
Phase 1/2 Terminated
NCT00053326 2013-10-08
Fenretinide in Treating Children With Recurrent or Resistant Neuroblastoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00009932 2013-05-15
Combination Chemotherapy in Treating Patients With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Unknown
NCT00077402 2013-05-15
Fenretinide In Treating Patients With Advanced or Metastatic Hormone-Refractory Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00026091 2013-03-25
Fenretinide in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00009971 2013-02-11
Fenretinide in Treating Patients With Recurrent Small Cell Lung Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003191 2013-02-07
Fenretinide in Treating Children With Solid Tumors
National Cancer Institute (NCI)
Phase 1 Completed
NCT00002646 2012-01-05
Hormone Therapy in Treating Postmenopausal Women With Receptor-Positive Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00001378 2008-03-04
A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed